scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010804907 |
P356 | DOI | 10.1038/NRI3582 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nri3582 |
P698 | PubMed publication ID | 24445665 |
P5875 | ResearchGate publication ID | 259826273 |
P50 | author | Bart Lambrecht | Q18402373 |
Martin Guilliams | Q48148352 | ||
Yvan Saeys | Q48577555 | ||
Pierre Bruhns | Q56435969 | ||
P2093 | author name string | Hamida Hammad | |
P2860 | cites work | Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions | Q24532135 |
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) | Q24633690 | ||
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells | Q24643634 | ||
Exploring the full spectrum of macrophage activation | Q24653754 | ||
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function | Q24684586 | ||
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania | Q25256801 | ||
Translating basic mechanisms of IgG effector activity into next generation cancer therapies | Q26991899 | ||
Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets | Q28140238 | ||
The complexity of antibody-dependent enhancement of dengue virus infection | Q28250383 | ||
Functional characteristics of the high affinity IgG receptor, FcγRI. | Q37843085 | ||
Antibody-Fc receptor interactions in protection against intracellular pathogens. | Q37853942 | ||
Properties of mouse and human IgG receptors and their contribution to disease models | Q38005653 | ||
The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases | Q38042219 | ||
Regulation of Phagocytosis and [Ca 2+ ] i Flux by Distinct Regions of an Fc Receptor | Q38514533 | ||
Staphylococcus aureus-induced plasmacytoid dendritic cell activation is based on an IgG-mediated memory response | Q39943911 | ||
TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. | Q40653215 | ||
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo | Q40749020 | ||
Secretory phospholipase A(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: potential relevance for atherogenesis | Q40757763 | ||
Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells | Q40763824 | ||
The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex | Q40924258 | ||
syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes | Q41015817 | ||
Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. | Q41166947 | ||
Fc receptor biology | Q41464279 | ||
Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG | Q41613221 | ||
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes | Q41618456 | ||
Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb | Q42006236 | ||
Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro | Q42022012 | ||
Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake | Q42091841 | ||
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies | Q42445183 | ||
Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells. | Q42514349 | ||
Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection | Q42646009 | ||
Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen | Q43468956 | ||
FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens | Q44620514 | ||
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences | Q46516651 | ||
Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. | Q46876439 | ||
Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells | Q47681830 | ||
IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10 | Q50335926 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Fcgamma receptors: old friends and new family members | Q28291895 | ||
Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future | Q28292558 | ||
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection | Q28504795 | ||
The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells | Q28508363 | ||
Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake | Q28511010 | ||
FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation | Q28588375 | ||
FcgammaRIV: a novel FcR with distinct IgG subclass specificity | Q28594064 | ||
The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
Fcgamma receptors as regulators of immune responses | Q29615584 | ||
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response | Q29616156 | ||
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 | ||
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 | Q29622852 | ||
Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells | Q33206586 | ||
Cytokine-regulated expression and inhibitory function of FcgammaRIIB1 and -B2 receptors in human dendritic cells | Q33225793 | ||
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor | Q33335777 | ||
IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity | Q33347095 | ||
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease | Q33347581 | ||
Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. | Q33367336 | ||
Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells | Q33371273 | ||
Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo | Q33398737 | ||
The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy | Q33405125 | ||
Intravenous immunoglobulin therapy: how does IgG modulate the immune system? | Q33405903 | ||
Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. | Q33518557 | ||
Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors | Q33562297 | ||
Fcgamma receptors: structure, function and role as genetic risk factors in SLE | Q33697484 | ||
Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. | Q33731760 | ||
Fc receptor signaling and trafficking: a connection for antigen processing | Q33815451 | ||
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells | Q33865201 | ||
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo | Q33907906 | ||
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines | Q33928636 | ||
Sabotage and exploitation in macrophages parasitized by intracellular protozoans | Q33984255 | ||
CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. | Q50787445 | ||
Human inflammatory dendritic cells induce Th17 cell differentiation. | Q50917340 | ||
IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. | Q51002504 | ||
Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. | Q52486393 | ||
Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. | Q53584954 | ||
Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion. | Q53901177 | ||
Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. | Q54454274 | ||
CD64 Expression Distinguishes Monocyte-Derived and Conventional Dendritic Cells and Reveals Their Distinct Role during Intramuscular Immunization | Q57275355 | ||
Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs | Q57920497 | ||
Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo | Q58234959 | ||
Activation of Human Plasmacytoid Dendritic Cells by TLR9 Impairs Fc RII-Mediated Uptake of Immune Complexes and Presentation by MHC Class II | Q58619971 | ||
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin | Q58864690 | ||
Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same Antigen | Q72811339 | ||
Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells | Q78946086 | ||
Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation | Q79445161 | ||
FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis | Q79930067 | ||
Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses | Q80257343 | ||
FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice | Q81022674 | ||
HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers | Q81468722 | ||
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells | Q81476297 | ||
Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells | Q81672093 | ||
Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells | Q81724341 | ||
Intracellular antibody-mediated immunity and the role of TRIM21 | Q82069556 | ||
Fcgamma receptor-mediated antigen uptake by lung DC contributes to allergic airway hyper-responsiveness and inflammation | Q82863640 | ||
Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis | Q83239526 | ||
The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease | Q84521125 | ||
Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells | Q85259274 | ||
Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells | Q85634389 | ||
IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling. | Q36793403 | ||
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses | Q36882237 | ||
Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. | Q36903830 | ||
FcRn: the neonatal Fc receptor comes of age. | Q36912134 | ||
Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. | Q36959840 | ||
Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice | Q36967895 | ||
Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIa | Q37078202 | ||
Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages | Q37097916 | ||
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. | Q37194936 | ||
Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes | Q37206862 | ||
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. | Q37222231 | ||
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice | Q37350204 | ||
Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin | Q37405187 | ||
Inhibitory ITAMs as novel regulators of immunity. | Q37631690 | ||
The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease | Q37698818 | ||
Deciphering the transcriptional network of the dendritic cell lineage | Q37700905 | ||
FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. | Q37736263 | ||
Modulation of host cell function by Legionella pneumophila type IV effectors | Q37798551 | ||
IgE regulates T helper cell differentiation through FcgammaRIII mediated dendritic cell cytokine modulation. | Q33987889 | ||
Modulation of innate immunity by Toxoplasma gondii virulence effectors | Q34033981 | ||
Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen | Q34161524 | ||
Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. | Q34377438 | ||
Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue | Q34471984 | ||
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes | Q34650719 | ||
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes | Q34671059 | ||
Immune complex-mediated antigen presentation induces tumor immunity | Q34793164 | ||
Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin | Q35030843 | ||
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells | Q35049100 | ||
Transcriptomes of the B and T lineages compared by multiplatform microarray profiling | Q35117503 | ||
Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. | Q35834611 | ||
Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis | Q35834623 | ||
Characterization of resident and migratory dendritic cells in human lymph nodes | Q35894149 | ||
Mast cells and company | Q35927793 | ||
Autonomous phagosomal degradation and antigen presentation in dendritic cells | Q36221894 | ||
Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity | Q36227843 | ||
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors | Q36228422 | ||
Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia | Q36229077 | ||
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program | Q36229419 | ||
Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. | Q36229572 | ||
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells | Q36333494 | ||
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization | Q36367948 | ||
Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis | Q36368360 | ||
Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells | Q36369741 | ||
Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo | Q36371253 | ||
Selective suppression of interleukin-12 induction after macrophage receptor ligation | Q36377302 | ||
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. | Q36402668 | ||
FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. | Q36403918 | ||
Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation | Q36579451 | ||
Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling | Q36673501 | ||
Dependence of antibody-mediated presentation of antigen on FcRn | Q36756942 | ||
P2507 | corrigendum / erratum | Erratum: The function of Fcγ receptors in dendritic cells and macrophages | Q57920432 |
P433 | issue | 2 | |
P921 | main subject | macrophage | Q184204 |
dendritic cell | Q506253 | ||
P304 | page(s) | 94-108 | |
P577 | publication date | 2014-01-21 | |
P1433 | published in | Nature Reviews Immunology | Q43355 |
P1476 | title | The function of Fcγ receptors in dendritic cells and macrophages | |
P478 | volume | 14 |
Q40054103 | (5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling |
Q58799522 | A novel probe to assess cytosolic entry of exogenous proteins |
Q92340157 | AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models |
Q89606305 | Adenovirus-Antibody Complexes Contributed to Lethal Systemic Inflammation in a Gene Therapy Trial |
Q37377083 | Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity. |
Q35919896 | Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets |
Q26778149 | Alzheimer's Disease: Mechanism and Approach to Cell Therapy |
Q35815718 | An Emerging Approach for Parallel Quantification of Intracellular Protozoan Parasites and Host Cell Characterization Using TissueFAXS Cytometry |
Q64111519 | An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages |
Q40049822 | An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge |
Q52647916 | Analysis of the association between Fc receptor family gene polymorphisms and ocular Behçet's disease in Han Chinese. |
Q35483850 | Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms |
Q63246493 | Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells |
Q30252022 | Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead. |
Q28067735 | Antibodies and tuberculosis |
Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics |
Q63246407 | Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses |
Q36118373 | Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses |
Q37689507 | Antigen cross-presentation of immune complexes |
Q35212575 | Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution |
Q33867299 | Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design |
Q92645982 | Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression |
Q38827908 | Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells. |
Q49048144 | Barrier-tissue macrophages: functional adaptation to environmental challenges. |
Q47602559 | Beyond binding: antibody effector functions in infectious diseases. |
Q35798763 | Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke |
Q92256253 | Both IgM and IgG Antibodies Against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice |
Q37512871 | Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies |
Q51761548 | C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. |
Q47162111 | C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6. |
Q48246976 | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes |
Q27303810 | CD103+ CD11b+ Dendritic Cells Induce Th17 T Cells in Muc2-Deficient Mice with Extensively Spread Colitis |
Q37425277 | CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus |
Q59798728 | CD32 Ligation Promotes the Activation of CD4+ T Cells |
Q40290840 | CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses |
Q38257496 | CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity |
Q47718174 | Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction |
Q36286498 | Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients |
Q89995322 | Characterization and Protective Activity of Monoclonal Antibodies Directed against Streptococcus suis Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate |
Q39454978 | Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors |
Q93020630 | Class II MHC antigen processing in immune tolerance and inflammation |
Q49691927 | Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis. |
Q64280631 | Commentary: Fc Gamma Receptors are Expressed in the Developing Rat Brain and Activate Downstream Signaling Molecules upon Cross-Linking with Immune Complex |
Q64101963 | Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus |
Q33686907 | Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies |
Q28085328 | Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity |
Q47112430 | Conventional CD11chigh Dendritic Cells Are Important for T Cell Priming during the Initial Phase of Plasmodium yoelii Infection, but Are Dispensable at Later Time Points |
Q39260017 | Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells. |
Q33627385 | DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo. |
Q92712565 | Delivery of Antigen to CD8+ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity |
Q38869727 | Dendritic cell maturation and cross-presentation: timing matters! |
Q40096151 | Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression |
Q26752558 | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
Q83227399 | Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses |
Q40565798 | Discriminative expression of whole blood genes in HIV patients with latent and active TB in Ethiopia |
Q60221622 | Dissecting FcγR Regulation through a Multivalent Binding Model |
Q38587703 | Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach. |
Q35754076 | Distribution of immunoglobulin G antibody secretory cells in small intestine of Bactrian camels (Camelus bactrianus) |
Q33715167 | Diversity and Versatility of Phagocytosis: Roles in Innate Immunity, Tissue Remodeling, and Homeostasis |
Q40514614 | Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization. |
Q41782754 | Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes |
Q89435524 | Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies |
Q46775195 | Empirical evidence of cold stress induced cell mediated and humoral immune response in common myna (Sturnus tristis). |
Q91844658 | Engineering the interactions between a plant-produced HIV antibody and human Fc receptors |
Q38792889 | Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells |
Q37554718 | Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses |
Q57920432 | Erratum: The function of Fcγ receptors in dendritic cells and macrophages |
Q64106814 | Evaluation of Assays to Assess the Modulation of Dendritic Cells Functions by Therapeutic Antibodies and Aggregates |
Q90212184 | Factors Affecting the Pharmacology of Antibody-Drug Conjugates |
Q33694522 | Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. |
Q40560816 | Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody. |
Q40404277 | Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis |
Q92756081 | Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial |
Q47202386 | Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex |
Q26783175 | Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases |
Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
Q57065809 | Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression |
Q49832498 | Fc-mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. |
Q48193708 | FcRn is mother's milk to allergen tolerance |
Q38239281 | FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions |
Q28076012 | Fcγ Receptors in Solid Organ Transplantation |
Q38615357 | Fcγ receptor pathways during active and passive immunization |
Q38615347 | Fcγ receptors: genetic variation, function, and disease. |
Q49847008 | FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibody. |
Q38788604 | FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells. |
Q90614167 | FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions |
Q41583979 | Food Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins |
Q34478033 | Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice |
Q59813339 | Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage |
Q40641101 | Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus |
Q59807319 | Gene Regulatory Network Modeling of Macrophage Differentiation Corroborates the Continuum Hypothesis of Polarization States |
Q54263042 | Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. |
Q45963418 | HIV: Finding latent needles in a haystack. |
Q90212766 | Harnessing the immune system via FcγR function in immune therapy: A pathway to next-gen mAbs |
Q90007774 | Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells |
Q40375806 | Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies |
Q107138460 | High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages |
Q59355752 | Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome |
Q45006012 | Host-Directed Therapeutic Strategies for Tuberculosis |
Q26745538 | Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors |
Q40054966 | Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses |
Q60647750 | Human IgG1 antibodies suppress angiogenesis in a target-independent manner |
Q26779758 | Human IgG4: a structural perspective |
Q40145966 | Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate. |
Q93250294 | Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses |
Q42373352 | IFNγ Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized with Human Syphilitic Serum by Human Macrophages |
Q49344272 | Identification of a Potential Common Ancestor for Mammalian Cross-Presenting Dendritic Cells in Teleost Respiratory Surfaces. |
Q36025549 | IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses |
Q88219084 | IgE/antigen-mediated enhancement of IgE production is a mechanism underlying the exacerbation of airway inflammation and remodelling in mice |
Q64118813 | IgG and Fcγ Receptors in Intestinal Immunity and Inflammation |
Q92702147 | IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways |
Q34368678 | IgG subclasses and allotypes: from structure to effector functions |
Q47099530 | IgG subclasses determine pathways of anaphylaxis in mice. |
Q58591907 | IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance |
Q88780377 | Imaging Reporter Strategy to Monitor Gene Activation of Microglia Polarisation States under Stimulation |
Q90197426 | ImmGen report: sexual dimorphism in the immune system transcriptome |
Q39540023 | Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages |
Q100490839 | Immune characterization of pre-clinical murine models of neuroblastoma |
Q41564465 | Immune complex negatively regulates Toll-like receptor 9-mediated immune responses in B cells through the inhibitory Fc-gamma receptor IIb. |
Q47120108 | Immune complex negatively regulates toll-like receptor 3-triggered tumour necrosis factor α production in B cells |
Q38615391 | Immune regulation by Fcα/μ receptor (CD351) on marginal zone B cells and follicular dendritic cells |
Q93357641 | Immune system responses in Parkinson's disease: Early and dynamic |
Q36106053 | Immunity, inflammation, and cancer: an eternal fight between good and evil |
Q48256010 | Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy. |
Q38344833 | Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all? |
Q54014963 | Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo. |
Q26738396 | Immunoregulatory functions of immune complexes in vaccine and therapy |
Q64949957 | Immunotherapy with Native Molecule rather than Hypoallergenic Variant of Pru p 3, the Major Peach Allergen, Shows Beneficial Effects in Mice. |
Q97883509 | Impact of Plasma Membrane Domains on IgG Fc Receptor Function |
Q36182299 | Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation |
Q40745788 | Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain |
Q26781290 | Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity |
Q94554560 | Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection |
Q64925019 | Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. |
Q55387054 | Innate immune receptors drive dengue virus immune activation and disease. |
Q38847426 | Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1. |
Q55044025 | Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21. |
Q52800548 | Intraperitoneal Immunization with Cry1Ac Protoxin from Bacillus thuringiensis Provokes Upregulation of Fc-Gamma-II/and Fc-Gamma-III Receptors Associated with IgG in the Intestinal Epithelium of Mice. |
Q60647752 | Intravenous immune globulin suppresses angiogenesis in mice and humans |
Q59351768 | Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy |
Q28081718 | Is infant immunization by breastfeeding possible? |
Q90690112 | Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype |
Q64913821 | Leishmania infantum Virulence Factor A2 Protein: Linear B-Cell Epitope Mapping and Identification of Three Main Linear B-Cell Epitopes in Vaccinated and Naturally Infected Dogs. |
Q102211190 | Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19 |
Q46572905 | Ligation of FcγR Alters Phagosomal Processing of Protein via Augmentation of NADPH Oxidase Activity |
Q40278997 | Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes |
Q41731948 | Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses. |
Q35113222 | Local immunosuppressive microenvironment enhances migration of melanoma cells to lungs in DJ-1 knockout mice |
Q53393080 | Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV. |
Q41842699 | Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells. |
Q26783493 | M2e-Based Universal Influenza A Vaccines |
Q27007951 | Macrophage proliferation, provenance, and plasticity in macroparasite infection |
Q35641157 | Macrophages Are Phenotypically and Functionally Diverse across Tissues in Simian Immunodeficiency Virus-Infected and Uninfected Asian Macaques |
Q39331723 | Macrophages as Effectors of Acute and Chronic Allograft Injury |
Q91868507 | Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection |
Q26853371 | Mass cytometry: a highly multiplexed single-cell technology for advancing drug development |
Q47574862 | Maternal IgG immune complexes induce food allergen-specific tolerance in offspring. |
Q58775766 | Messing with the Sentinels-The Interaction of with Dendritic Cells |
Q26781338 | Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications |
Q38760836 | Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model |
Q48278134 | Modulation of IgG1 immunoeffector function by glycoengineering of the GDP-fucose biosynthesis pathway. |
Q37626070 | Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection |
Q50133260 | Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn binding. |
Q26825548 | Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases |
Q39258320 | Monocyte differentiation and antigen-presenting functions |
Q38615349 | Mouse and human FcR effector functions |
Q37677278 | Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles |
Q47148202 | Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions. |
Q90341760 | Murine macrophage TLR2-FcγR synergy via FcγR licensing of IL-6 cytokine mRNA ribosome binding and translation |
Q39364012 | Myeloperoxidase-Oxidized LDLs Enhance an Anti-Inflammatory M2 and Antioxidant Phenotype in Murine Macrophages. |
Q40134053 | Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine. |
Q55314061 | Notch signaling regulates the responses of lipopolysaccharide-stimulated macrophages in the presence of immune complexes. |
Q90485498 | OMIP-051 - 28-color flow cytometry panel to characterize B cells and myeloid cells |
Q38991048 | Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments |
Q50073556 | Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. |
Q90211749 | Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients |
Q93018133 | Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival |
Q40284594 | Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants |
Q37074015 | Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine |
Q34542687 | Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein |
Q92471671 | Reciprocal immune enhancement of dengue and Zika virus infection in human skin |
Q40039898 | Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice. |
Q58554208 | Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization |
Q28066034 | Regulation of immunity during visceral Leishmania infection |
Q89978292 | Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer |
Q64107587 | Research and development of new tuberculosis vaccines: a review |
Q38782706 | Role of Fc-FcγR interactions in the antitumor activity of therapeutic antibodies |
Q30855264 | Screening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis |
Q92538845 | Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection |
Q33724997 | Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model |
Q35946462 | Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice. |
Q28553042 | Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect |
Q39189720 | Single-cell RNA-seq ties macrophage polarization to growth rate of intracellular Salmonella. |
Q45342736 | Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen |
Q90730861 | Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium |
Q38615376 | Structural analysis of Fc/FcγR complexes: a blueprint for antibody design. |
Q40388373 | Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI. |
Q59135850 | Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients |
Q35102339 | Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection |
Q33443533 | Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain. |
Q36296686 | Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate |
Q53396845 | Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. |
Q64102267 | Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy-Focus on FcγRIIB |
Q64240465 | The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies |
Q89861405 | The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit |
Q35665034 | The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution |
Q92239387 | The Neonatal Fc Receptor (FcRn): A Misnomer? |
Q39088502 | The Role and Function of Fcγ Receptors on Myeloid Cells |
Q26852988 | The Role of FcRn in Antigen Presentation |
Q41354182 | The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes |
Q47103062 | The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages. |
Q64945497 | The inflammatory function of human IgA. |
Q37493320 | The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis |
Q33817936 | The journey from stem cell to macrophage |
Q38936522 | The life cycle of phagosomes: formation, maturation, and resolution |
Q47810222 | The pathophysiology of anaphylaxis |
Q58714558 | The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens |
Q38365223 | The role of FcεRI expressed in dendritic cells and monocytes |
Q28075279 | The role of genetics and antibodies in sepsis |
Q38920840 | The role of selected flavonols in tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) expression on activated RAW 264.7 macrophages. |
Q49684254 | The roles of CSFs on the functional polarization of tumor-associated macrophages. |
Q38879903 | The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state |
Q36383442 | The transcriptional profile of coronary arteritis in Kawasaki disease |
Q90053512 | Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cells |
Q49242675 | Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity. |
Q38896842 | Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages |
Q38232105 | Type I and type II Fc receptors regulate innate and adaptive immunity |
Q54217613 | Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis. |
Q83230893 | Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells |
Q64057499 | Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses |
Q28545783 | Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis |
Q35823060 | Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification |
Q37244315 | miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells |
Q57920432 | Erratum: The function of Fcγ receptors in dendritic cells and macrophages | main subject | P921 |
Search more.